Advancements in single-use equipment are crucial to the development of the biotechnology industry, according to experts at this year’s Interphex.

Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant.

Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.

Unilife is expanding its large dose delivery platform in a bid to meet a “growing industry need” for at-home drug administration in bigger scale.

Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials.

Excipient makers could save up to 200 man hours with a new industry-driven, third-party audit certification scheme set to launch next week.

Taste masking plays a vital role in treatment compliance according to Cargill, which has launched a new flavour technology that it claims can make drugs more pleasant to take and help manufacturers save money.

High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market.

Endeavour Specialty Chemicals has launched a novel range of pyridinyl thioureas designed to cater for growing pharmaceutical industry interest in the development of prion disease treatments.

BASF says solubility and bioavailability will be key focus for its pharmaceutical excipient product development efforts in the next few years.